Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Ferrari

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Stem Cell Research|September 16, 2018
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7Elisa Maria Turco, Ersilia Vinci, Filomena Altieri, et al.
Stem Cell Research|June 9, 2024
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A)Alessia Casamassa, Giovannina Rotundo, Chiara Ceresoni, et al.
Stem Cell Research|September 8, 2019
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA)Eris Bidollari, Giovannina Rotundo, Filomena Altieri, et al.
Stem Cell Research|September 11, 2024
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome regionAngela Maria Giada Giovenale, Elisa Maria Turco, Martina Mazzoni, et al.
Expert Opinion on Biological Therapy|August 20, 2024
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosisLetizia Mazzini, Fabiola De Marchi, Leonora Buzanska, et al.
Stem Cell Research|June 10, 2026
Generation and characterization of the hiPSC line CSSi023-A (16154) from a patient with ADOA caused by an OPA1 variantAngela Maria Giada Giovenale, Ilaria Ferrone, Silvia Tomaselli, et al.
Stem Cell Research|August 31, 2025
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2AAngela Maria Giada Giovenale, Ilaria Ferrone, Silvia Tomaselli, et al.
Expert Opinion on Biological Therapy|July 21, 2018
Advances in stem cell therapy for amyotrophic lateral sclerosisLetizia Mazzini, Daniela Ferrari, Pavle R Andjus, et al.
Blood|March 2, 2006
Innate immunity defects in Hermansky-Pudlak type 2 syndromeStefania Fontana, Silvia Parolini, William Vermi, et al.
Stem Cell Research|May 1, 2025
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutationAngela Maria Giada Giovenale, Elisa Maria Turco, Ilaria Ferrone, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Stem Cell Research|September 16, 2018
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7Elisa Maria Turco, Ersilia Vinci, Filomena Altieri, et al.
Stem Cell Research|June 9, 2024
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A)Alessia Casamassa, Giovannina Rotundo, Chiara Ceresoni, et al.
Stem Cell Research|September 8, 2019
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA)Eris Bidollari, Giovannina Rotundo, Filomena Altieri, et al.
Stem Cell Research|September 11, 2024
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome regionAngela Maria Giada Giovenale, Elisa Maria Turco, Martina Mazzoni, et al.
Expert Opinion on Biological Therapy|August 20, 2024
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosisLetizia Mazzini, Fabiola De Marchi, Leonora Buzanska, et al.
Stem Cell Research|June 10, 2026
Generation and characterization of the hiPSC line CSSi023-A (16154) from a patient with ADOA caused by an OPA1 variantAngela Maria Giada Giovenale, Ilaria Ferrone, Silvia Tomaselli, et al.
Stem Cell Research|August 31, 2025
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2AAngela Maria Giada Giovenale, Ilaria Ferrone, Silvia Tomaselli, et al.
Expert Opinion on Biological Therapy|July 21, 2018
Advances in stem cell therapy for amyotrophic lateral sclerosisLetizia Mazzini, Daniela Ferrari, Pavle R Andjus, et al.
Blood|March 2, 2006
Innate immunity defects in Hermansky-Pudlak type 2 syndromeStefania Fontana, Silvia Parolini, William Vermi, et al.
Stem Cell Research|May 1, 2025
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutationAngela Maria Giada Giovenale, Elisa Maria Turco, Ilaria Ferrone, et al.
Pageof 9